Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Trends in Molecular Medicine|August 4, 2018
An Experimenter's Guide to Glioblastoma Invasion PathwaysMark C de Gooijer, Miriam Guillén Navarro, Rene Bernards, et al.Investigational New Drugs|November 18, 2017
ATP-binding cassette transporters limit the brain penetration of Wee1 inhibitorsMark C de Gooijer, Levi C M Buil, Jos H Beijnen, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 26, 2012
Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detectionFan Lin, Gayathri Chandrasekaran, Mark C de Gooijer, et al.Biomedical Chromatography : BMC|May 2, 2025
Development and Validation of a Rapid and Simple LC-MS/MS Method for Quantification of the Anti-Microtubule, Anti-Cancer Agent ABT-751 in Human and Mouse Plasma and Mouse TissuesAristeidis Lentzas, Anna Their, Jos H Beijnen, et al.CNS Oncology|July 24, 2014
Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug effluxFan Lin, Mark C de Gooijer, Diana Hanekamp, et al.International Journal of Cancer|September 19, 2017
The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitorsMark C de Gooijer, Ping Zhang, Ruud Weijer, et al.FEBS Open Bio|April 12, 2017
The G2 checkpoint-a node-based molecular switchMark C de Gooijer, Arnout van den Top, Irena Bockaj, et al.International Journal of Cancer|April 15, 2015
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-InhibitorsPing Zhang, Mark C de Gooijer, Levi C M Buil, et al.Molecular Pharmaceutics|September 26, 2018
ABCB1 Attenuates the Brain Penetration of the PARP Inhibitor AZD2461Mark C de Gooijer, Levi C M Buil, Ceren H Çitirikkaya, et al.Cell Reports|July 7, 2017
Identification of a Druggable Pathway Controlling Glioblastoma InvasivenessNora Pencheva, Mark C de Gooijer, Daniel J Vis, et al.Pageof 3